Syros Pharmaceuticals (SYRS) IPO Pushes Higher Into the Close
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
Go back to Syros Pharmaceuticals (SYRS) IPO Pushes Higher Into the Close
June 30, 2016 11:20 AM EDT
Today's IPO for Syros Pharmaceuticals (Nasdaq: SYRS) opened for trading at $15 after pricing its initial public offering of 4,000,000 shares of its common stock at a public offering price of $12.50 per share. The company was previously expecting the IPO to price from $14 to $16 per... More
June 30, 2016 6:26 AM EDT
Syros Pharmaceuticals (Nasdaq: SYRS) announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a public offering price of $12.50 per share, before underwriting discounts and commissions. In addition, Syros has granted the underwriters a 30-day option to purchase up to 600,000 additional shares of common stock from Syros at the public offering price, less the underwriting discount and commissions, to cover over-allotments, if any. All of the shares are being offered by Syros Pharmaceuticals. The Companys shares are scheduled to begin trading on The NASDAQ Global Select Market on June 30,... More
